Prof. Dr. dr. Sri Rezeki Hadinegoro, Sp.A(K)
Medical Advisor - Investigator

- Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 years in Asia (CYD14)
- 2012
https://scholar.ui.ac.id/en/publications/clinical-efficacy-and-safety-of-a-novel-tetravalent-dengue-vaccin - A multicenter seroprevalence cross-sectional study from 30 geographically dispersed clusters in Indonesia (DNG26)
- 2014
https://pubmed.ncbi.nlm.nih.gov/28617803/ - A multi-country, epidemiologic, study to assess the interferon gamma release essay (IGRA) positivity, and to build capacity to conduct a tuberculosis (TB) vaccine efficacy study in populations with a high TB disease burden (TBV02-E01)
- Dengue shock syndrome: clinical manifestations, management and outcome - a hospital-based study in Jakarta, Indonesia
https://www.cabidigitallibrary.org/doi/full/10.5555/20013094587 - Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0297041